Anixa Biosciences Inc. (ANIX) is a publicly traded life sciences firm focused on developing therapeutic and diagnostic products for oncology and infectious disease indications. As of 2026-04-03, ANIX is trading at a current price of $2.55, marking a 6.25% drop in its most recent trading session. No recent earnings data is available for the company as of this analysis. This report covers key market context shaping near-term price action, critical technical support and resistance levels, and poten
ANIX Stock Analysis: Anixa Biosciences Inc down 6.25 pct to $2.55 biotech update
ANIX - Stock Analysis
4369 Comments
818 Likes
1
Jaecyon
Active Contributor
2 hours ago
{协议答案}
👍 147
Reply
2
Jatayvion
Active Contributor
5 hours ago
{协议答案}
👍 111
Reply
3
Dalay
Legendary User
1 day ago
{协议答案}
👍 148
Reply
4
Nayture
Experienced Member
1 day ago
{协议答案}
👍 118
Reply
5
Alexee
Trusted Reader
2 days ago
{协议答案}
👍 161
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.